Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung

被引：15
|
作者：
Reichegger, Hermann [1 ]
Jochum, Wolfram [2 ]
Forbs, Diana [2 ]
Hader, Claudia [3 ]
Fruh, Martin [1 ]
机构：
[1] Kantonsspital St Gallen, Dept Med Oncol & Hematol, Rorschacherstr 95, CH-9007 St Gallen, Switzerland
[2] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[3] Kantonsspital St Gallen, Dept Radiol & Nucl Med, St Gallen, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷 / 7-8期
关键词：
AZD9291; Osimertinib; Intracranial; Lung cancer; Response; EGFR mutation; T790M; EGFR-TKI; ACQUIRED-RESISTANCE; CANCER; AZD9291; METASTASES; INHIBITORS; MUTATION;
D O I：
10.1159/000446759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Osimertinib (AZD9291, Tagrisso) is a potent, irreversible third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Case Report: Our report demonstrates that osimertinib is able to inhibit the growth of a radiotherapy- and surgery-refractory EGFR T790M-positive brain metastasis in a patient with lung adenocarcinoma. Conclusion: These data show that re-biopsy in EGFR-mutated non-small cell lung cancer patients with acquired TKI resistance should be performed. (C) 2016 S. Karger GmbH, Freiburg
引用
收藏
页码：461 / 463
页数：3
相关论文
共 50 条
  • [1] Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma
    Liu, Yang
    Xiong, Zhi-Cheng
    Sun, Xin
    Sun, Li
    Zhang, Shu-Ling
    Ma, Jie-Tao
    Han, Cheng-Bo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2151 - 2163
  • [2] Osimertinib in EGFR T790M-Positive Lung Cancer
    Nishino, Mizuki
    Hatabu, Hiroto
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1992 - 1993
  • [3] Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
    Matsumoto, Yoshiya
    Kawaguchi, Tomoya
    Yamamoto, Norio
    Sawa, Kenji
    Yoshimoto, Naoki
    Suzumura, Tomohiro
    Watanabe, Tetsuya
    Mitsuoka, Shigeki
    Asai, Kazuhisa
    Kimura, Tatsuo
    Yoshimura, Naruo
    Kuwae, Yuko
    Hirata, Kazuto
    INTERNAL MEDICINE, 2017, 56 (17) : 2325 - 2328
  • [4] Sustained response to standard dose osimertinib in a patient with plasma T790M-positive leptomeningeal metastases from primary lung adenocarcinoma
    Chan, Oscar Siu-Hong
    Leung, Warren Kam-Wing
    Yeung, Rebecca Mei-Wan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (06) : 428 - 430
  • [5] Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
    Ohe, Yuichiro
    Kato, Terufumi
    Sakai, Fumikazu
    Kusumoto, Masahiko
    Endo, Masahiro
    Saito, Yoshinobu
    Baba, Tomohisa
    Sata, Masafumi
    Yamaguchi, Ou
    Sakamoto, Kei
    Sugeno, Masatoshi
    Tamura, Reiko
    Tokimoto, Toshimitsu
    Shimizu, Wataru
    Gemma, Akihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 909 - 919
  • [6] Osimertinib effective in EGFR T790M-positive lung cancer
    Mayor, Susan
    LANCET ONCOLOGY, 2017, 18 (01): : E9 - E9
  • [7] Osimertinib Administration as the Primary Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy for Brain Metastasis of De Novo T790M-positive Lung Cancer
    Noguchi, Susumu
    Kawachi, Hiroaki
    Fukao, Akari
    Terashita, Satoshi
    Tajiri, Tomoko
    Ikeue, Tatsuyoshi
    Horikawa, Sadao
    Sugita, Takakazu
    INTERNAL MEDICINE, 2019, 58 (20) : 3029 - 3031
  • [8] Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient
    Metro, Giulio
    Baglivo, Sara
    Siggillino, Annamaria
    Ludovini, Vienna
    Chiari, Rita
    Rebonato, Alberto
    Bellezza, Guido
    CLINICAL DRUG INVESTIGATION, 2018, 38 (10) : 983 - 987
  • [9] Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient
    Giulio Metro
    Sara Baglivo
    Annamaria Siggillino
    Vienna Ludovini
    Rita Chiari
    Alberto Rebonato
    Guido Bellezza
    Clinical Drug Investigation, 2018, 38 : 983 - 987
  • [10] Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib
    Yamasaki, Masahiro
    Funaishi, Kunihiko
    Daido, Wakako
    Hattori, Noboru
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (11): : 602 - 603
12345